Request for Funding
Medical Student Research Fellowship for Summer 2002
Mentor: Geri Brown, M.D.
Department: Internal Medicine
Room number: F4.124A
Mail Code: 9151
Phone number: 214-648-7929
E-mail: gbrow1@mednet.swmed.edu
Project title: Immune mediators of apoptosis in chronic hepatitis C Infection
Human subjects IRB approved project number (where applicable):
Animal subjects IRB approved project number (where applicable):
Project Type (patient-based research, animal-based research, or basic research; this characterization is only to permit a general classification for grouping similar types of projects) translational research. Using patient material and basic research technology
Brief Description of Project:
Unlike infections by other human hepatitis viruses, Hepatitis C virus (HCV)
infection of healthy immunocompetent adults is persistent or prolonged in the
vast majority of cases. In part, this undoubtedly relates to high rates of variability
in the amino acid sequence in the hypervariable region (HVR) 1 of the HCV envelope
protein which both result from immune pressure and permit "escape"
from neutralizing antibodies. However, in light of the important role of cytotoxic
T lymphocyte (CTL) responses in clearance of other non-cytopathic viruses, it
seems likely that HCV also has evolved strategies to evade human CTL responses.
Binding of the HCV core protein to the lymphotoxin $ receptor (LT$R) and interference
with LT$R signaling has been reported . Thus, interference with signaling through
the LT$R or other members of the TNFR family of receptors is one possible mechanism
whereby there is evasion of the human CTL responses. In addition, preliminary
studies indicate that there is up regulation of expression of protease inhibitor
9 (PI9), a serpin inhibitor of the human CTL effector molecule, granzyme B,
in human hepatoma cells infected in vitro with a Hepatitis C replicon. We propose
to study whether, during chronic HCV infection, there is evidence of enhanced
expression in the liver of PI9 or other serpins that may block CTL killing of
HCV infected hepatocytes or suppressed expression of the TNFR1, TNFR1, LT$R
and Fas family of "death" receptors that also may be important in
immune clearance of HCV infected cells. Quantitative real-time RT-PCR mRNA assays
for assessing levels of expression of these genes will be developed and used
to assess expression in liver biopsy specimens from patients with chronic hepatitis
C or with other forms of liver disease. Mono-specific antibodies for PI9 will
also be used to excess levels of PI9 protein expression in HCV infected versus
control liver specimens.
Previous Research Activities or Publications with Medical Students:
Return to UT Southwestern Homepage
Return to Student Research Projects Index